HCA

HCA Healthcare, Inc. (HCA Inc.) - 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2001, and the nine months ended on that date. HCA Inc. (formerly HCA - The Healthcare Company) is a holding company whose affiliates own and operate hospitals and related health care entities. As of September 30, 2001, affiliates operated 182 hospitals and 75 freestanding surgery centers across 24 U.S. states, England, and Switzerland. The company changed its name from "HCA - The Healthcare Company" to "HCA Inc." on July 1, 2001.

Key Financial Metrics

(Dollars in millions, except per share data)

Note: Total Debt calculated as Long-term debt ($6,312) + Long-term debt due within one year ($795). Working Capital calculated as Current Assets ($4,241) - Current Liabilities ($2,813).

Material Changes vs. Prior Period

• Profitability Surge: Net income for the nine months ended September 30, 2001, increased 326% to $845 million from $198 million in the prior year. This dramatic increase is primarily due to the absence of a $745 million accrual for a settlement with the Federal government recorded in the same period of 2000.
• Revenue Growth: Revenues increased 8.4% for the quarter and 7.3% for the nine months. This growth was driven by an 8.7% increase in revenue per equivalent admission, attributed to favorable managed care contract renewals and improved government reimbursement rates under the BIPA legislation.
• Asset Sales: The company recognized pretax gains of $112 million in the third quarter and $125 million for the nine months on the sale of hospitals and a managed care provider, compared to $20 million and $38 million, respectively, in the prior year.
• Government Settlement Payment: In August 2001, HCA paid the $745 million civil settlement to the Federal government. This payment significantly reduced cash and cash equivalents from $314 million at year-end 2000 to $74 million at September 30, 2001.
• Stock Repurchases: The company aggressively repurchased stock, spending $1.069 billion on repurchases during the first nine months of 2001, compared to $400 million in the prior year.

Guidance, Outlook, Risks, and Unusual Items

• Legal and Regulatory Risks: HCA remains subject to ongoing government investigations, including a formal order of investigation by the SEC regarding anti-fraud and internal accounting controls. The company faces numerous qui tam (whistleblower) actions and shareholder derivative suits. While a Corporate Integrity Agreement (CIA) was entered into to ensure Medicare compliance, future sanctions or penalties could materially adversely affect the company.
• Unusual Items:
  • Settlement with Federal Government: A $745 million charge was recorded in 2000; the payment was made in 2001, impacting cash flow but not 2001 earnings.
  • Impairment Charges: A non-cash, pretax charge of $17 million was recorded in Q3 2001 for the impairment of a non-hospital joint venture.
  • Restructuring Costs: $17 million in Q3 2001 and $44 million for the nine months were incurred for restructuring and investigation-related costs (primarily legal fees).
• Outlook: Management expects capital expenditures for 2001 to approximate $1.3 billion. The company anticipates continued investigative activity. Credit rating agencies (Moody's, S&P, Fitch) have maintained or upgraded outlooks to "positive" following the settlement and debt refinancing.

Investor Verification Checklist

• Settlement Impact: Verify the full extent of the $745 million payment's impact on liquidity and the remaining $250 million letter of credit obligation to the Department of Justice.
• SEC Investigation: Monitor the status of the SEC's formal order of investigation regarding anti-fraud and internal controls, as outcomes could lead to further penalties.
• Revenue Quality: Assess the sustainability of the 8.7% increase in revenue per equivalent admission, specifically regarding the shift from HMO to PPO business and government reimbursement changes.
• Debt Structure: Review the new 2001 Bank Loans ($1.75B revolving, $750M term) and the interest rate swap agreements used to manage variable rate exposure on $2.2 billion of debt.
• Stock Repurchase Program: Confirm the remaining authorization under the October 2001 $250 million repurchase plan and the status of the $500 million mandatorily redeemable securities of an affiliate.